Abbott Completes Separation of Research-Based Pharmaceuticals Business
date:Jan 04, 2013
said Mr. White. We have had enduring success precisely because of what we're doing now reinventing ourselves for changing times and creating new ways to serve the millions of patients, customers, communities and shareholders who depend on us.

Abbott begins its 125th year with approximately $22 billion in revenues generated throughout 150 countries and remains one of the largest and most far-reaching global healthcare companies, with diversity across technologies, businesses and geographies.


4/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/27 12:46